相似文献
1
Complete revascularisation in STEMI: consider the benefits but do not forget the risks!
Ann Transl Med. 2019 Dec;7(Suppl 8):S331. doi: 10.21037/atm.2019.09.121.
2
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2.
3
Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: an observational study.
Open Heart. 2017 Mar 15;4(1):e000541. doi: 10.1136/openhrt-2016-000541. eCollection 2017.
4
Early versus delayed complete revascularisation in patients presenting with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis of randomised controlled trials.
Open Heart. 2022 Jun;9(1). doi: 10.1136/openhrt-2022-001975.
6
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation.
Heart Lung Circ. 2021 Dec;30(12):1846-1853. doi: 10.1016/j.hlc.2021.06.522. Epub 2021 Aug 13.
7
Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.
EuroIntervention. 2019 Jun 20;15(2):172-179. doi: 10.4244/EIJ-D-18-00766.
8
Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
EuroIntervention. 2016 Nov 20;12(10):1231-1238. doi: 10.4244/EIJV12I10A203.
9
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1.
10
An Observational Study Assessing Immediate Complete Versus Delayed Complete Revascularisation in Patients with Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention.
Clin Med Insights Cardiol. 2020 Aug 21;14:1179546820951792. doi: 10.1177/1179546820951792. eCollection 2020.
本文引用的文献
1
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.
2
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.
Eur Heart J. 2019 Jan 7;40(2):79-80. doi: 10.1093/eurheartj/ehy855.
3
Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model.
JACC Cardiovasc Interv. 2018 Apr 23;11(8):717-724. doi: 10.1016/j.jcin.2017.11.028. Epub 2018 Mar 28.
4
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
N Engl J Med. 2017 Mar 30;376(13):1234-1244. doi: 10.1056/NEJMoa1701067. Epub 2017 Mar 18.
5
Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
JACC Cardiovasc Interv. 2017 Feb 27;10(4):315-324. doi: 10.1016/j.jcin.2016.11.047.
6
Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
Heart. 2016 Dec 15;102(24):1980-1987. doi: 10.1136/heartjnl-2015-308660. Epub 2016 Aug 8.
7
Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model.
JACC Cardiovasc Interv. 2016 Mar 28;9(6):602-13. doi: 10.1016/j.jcin.2016.01.001.
8
Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.
J Am Coll Cardiol. 2015 Dec 22;66(24):2713-2724. doi: 10.1016/j.jacc.2015.09.099.
9
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.
J Am Coll Cardiol. 2016 Mar 15;67(10):1235-1250. doi: 10.1016/j.jacc.2015.10.005. Epub 2015 Oct 21.
10
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1.
Zotero 插件